Targeted DNA RNA Sequencing Market Forecast to Surge to US$ 70.79 Bn Achieving a Remarkable 19.4% CAGR Forecast Period

Progressions in sequencing technologies that enhance preciseness and lessen prices are a prominent factor driving the targeted DNA RNA sequencing market.

NEW YORK CITY, NY, UNITED STATES, December 3, 2024 /EINPresswire.com/ -- The targeted DNA RNA sequencing market forecast for 2034 is a specialized study of the industry with a specific concentration on the global market trend analysis.

The targeted DNA RNA sequencing market is augmenting. The market is approximated to reach USD 70.79 billion by 2034. It was valued at USD 12.02 billion in 2024. It exhibited a CAGR of 19.4% from 2025 to 2034.

𝐖𝐡𝐚𝐭 𝐢𝐬 𝐓𝐚𝐫𝐠𝐞𝐭𝐞𝐝 𝐃𝐍𝐀 𝐑𝐍𝐀 𝐒𝐞𝐪𝐮𝐞𝐧𝐜𝐢𝐧𝐠?
RNA are polymeric molecules comprising nucleotides, important in coding, decoding, regulation, and formulation of genes. In the central principle of molecular biology, the genetic details of DNA are deciphered into manifold duplication of messengers RNA, which is subsequently interpreted into proteins. It is the biological operation that permits cells to fabricate multiple protein molecules from a solitary gene at a given point in time.

RNA specimens are normally splintered to a particular size gamut if one is researching the entire transcriptome or presenting mRNA sequencing. This is because of sequencing scrutiny length restrictions on prevalent NGS platforms. The growing demand for customized medicines is impacting the targeted DNA RNA sequencing market growth favorably.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/targeted-dna-rna-sequencing-market/request-for-sample?utm_source=EIN&utm_medium=EIN&utm_campaign=EIN&utm_id=01

𝐖𝐡𝐨 𝐌𝐚𝐤𝐞𝐬 𝐓𝐚𝐫𝐠𝐞𝐭𝐞𝐝 𝐃𝐍𝐀 𝐑𝐍𝐀 𝐒𝐞𝐪𝐮𝐞𝐧𝐜𝐢𝐧𝐠?

Illumina Inc., Thermo Fisher Scientific, Agilent Technologies, Roche Sequencing Solutions, QIAGEN, Pacific Biosciences, Oxford Nanopore Technologies, BGI Genomics, Genomatix Software, and Bio-Rad Laboratories are some of the leading players in the targeted DNA RNA sequencing market. The market aggression is influenced by fierce contention amidst the contenders, each struggling to advance more precise and economical sequencing conditions. This contention pushes the technological progressions, causing enhanced presentation and decreased prices of sequencing services.

𝐒𝐨𝐦𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐚𝐫𝐞:
• In August 2024, Thermo Fisher Scientific initiated a contemporary software suite outlined to smooth data analysis and enhance the translation of sequencing outcomes, mirroring its allegiance to progressing genomic research and clinical diagnostics.

• In July 2024, Illumina declared the instigation of its contemporary sequencing tool, the NovaSeq 6000, which aims to improve the productivity and preciseness of genomic sequencing.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/targeted-dna-rna-sequencing-market/request-for-discount-pricing?utm_source=EIN&utm_medium=EIN&utm_campaign=EIN&utm_id=01

𝐖𝐡𝐚𝐭’𝐬 𝐃𝐫𝐢𝐯𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐰𝐚𝐫𝐝?
• Growing Acquisition of NGS Technologies: The growing acquisition of next-generation sequencing technologies, augmentation of research in oncology and scarce illnesses, and the combination of sequencing data with alternate omics data to improve diagnostic and therapeutic programs are anticipated to surface as critical future trends in the market.

• Speedy Processing of Sequences: Progressions such as the advancement of the next-generation sequencing (NGS) platform improve the momentum, preciseness, and economy of sequencing. Firms such as Illumina and Thermo Fisher Scientific instigated elevated output sequencers that can process innumerable DNA RNA sequences speedily. This, in turn, is having a favorable impact on targeted DNA RNA sequencing market sales.

• Combining with Alternate Omics Data: The amalgamation of targeted DNA/RNA sequencing data with alternate omics data, such as proteomics and metabolomics, is surfacing as a notable trend. This multi-omics perspective offers a complete view of molecular apparatus elemental illnesses and eases more precise diagnostics and cure programs.

𝐖𝐡𝐢𝐜𝐡 𝐑𝐞𝐠𝐢𝐨𝐧 𝐋𝐞𝐚𝐝𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡?
• North America: North America accounted for the largest targeted DNA RNA sequencing market share. The region’s robust growth is primarily due to its progressive healthcare framework, elevated research investment, and notable funding in genomics and biotechnology. The region profits from the existence of spearheading sequencing technology firms, strong educational and clinical research potential, and an entrenched healthcare system that reinforces inventive genetic research and customized medicines.

• Europe: Europe is anticipated to witness significant growth from 2025 to 2034. This can be attributed to notable funding in research and development and a robust concentration on precision medicine.

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐛𝐞𝐟𝐨𝐫𝐞 𝐩𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/targeted-dna-rna-sequencing-market/inquire-before-buying?utm_source=EIN&utm_medium=EIN&utm_campaign=EIN&utm_id=01

𝐇𝐨𝐰 𝐈𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐃𝐨𝐧𝐞?
By Type Outlook:
• RNA-Based
• DNA-Based

By Method Outlook:
• Exome Sequencing
• Enrichment Sequencing
• Amplicon Sequencing
• Others

By Workflow Outlook:
• Pre-sequencing
• Sequencing
• Data Analysis

By End User Outlook:
• Academic Research
• Hospitals & Clinics
• Pharma & Biotech Entities
• Others

By Regional Outlook:
• North America
o US
o Canada

• Europe
o Germany
o France
o UK
o Italy
o Spain
o Netherlands
o Russia
o Rest of Europe

• Asia Pacific
o China
o Japan
o India
o Malaysia
o South Korea
o Indonesia
o Australia
o Vietnam
o Rest of Asia Pacific

• Middle East & Africa
o Saudi Arabia
o UAE
o Israel
o South Africa
o Rest of the Middle East & Africa
• Latin America
o Mexico
o Brazil
o Argentina
o Rest of Latin America

𝐅𝐀𝐐𝐬:
How much is the targeted DNA RNA sequencing market?
The market size was valued at USD 12.02 billion in 2024 and is projected to grow to USD 70.79 billion by 2034.

What is the growth rate of the targeted DNA RNA sequencing market?
The global market is projected to register a CAGR of 19.4% during the forecast period.

Which region held the largest market share?
North America accounted for the largest share of the global market in 2024.

Based on type, which segment held the larger share of the market?
The DNA-based sequencing segment accounted for a larger share of the global market.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
In Vitro Diagnostics Quality Control Market:
https://www.polarismarketresearch.com/industry-analysis/in-vitro-diagnostics-quality-control-market

Needle Holder Market:
https://www.polarismarketresearch.com/industry-analysis/needle-holder-market

Digital X-Ray Market:
https://www.polarismarketresearch.com/industry-analysis/digital-x-ray-market

Injection Pen Market:
https://www.polarismarketresearch.com/industry-analysis/injection-pen-market

Enteric Empty Capsules Market:
https://www.polarismarketresearch.com/industry-analysis/enteric-empty-capsules-market

𝐀𝐛𝐨𝐮𝐭 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 & 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠, 𝐈𝐧𝐜:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR’s clientele spread across different enterprises. We at Polaris are obliged to serve PMR’s diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR’s customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR’s customers.

Likhil G
Polaris Market Research and Consulting
+1 929-297-9727
sales@polarismarketresearch.com
Visit us on social media:
Facebook
X
LinkedIn